These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 11757557)

  • 21. Drug-free workplace programmes: New Zealand perspective.
    Nolan S
    Forensic Sci Int; 2008 Jan; 174(2-3):125-32. PubMed ID: 17467938
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The medical review officer: a potential role for the medical examiner.
    Sgan SL; Hanzlick R
    Am J Forensic Med Pathol; 2003 Dec; 24(4):346-50. PubMed ID: 14634473
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Performance-oriented packaging standards; revisions to transitional provisions--Department of Transportation. Final rule; partial response to petitions for reconsideration and revisions.
    Fed Regist; 1991 Sep; 56(181):47158-63. PubMed ID: 10114364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Drug abuse tests important part of preventive measures against narcotics. With testing drug abuse can be identified early in the workplace].
    Hermansson U; Beck O; Westregård A; Brunes M
    Lakartidningen; 2010 Nov 17-23; 107(46):2878-80. PubMed ID: 21197782
    [No Abstract]   [Full Text] [Related]  

  • 25. Infectious substances--DOT. Final rule.
    Fed Regist; 1995 Sep; 60(182):48780-7. PubMed ID: 10151186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Performance-enhancing drug use.
    Green GA
    Orthopedics; 2009 Sep; 32(9):. PubMed ID: 19751025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Legal issues in oral fluid testing.
    Kadehjian L
    Forensic Sci Int; 2005 Jun; 150(2-3):151-60. PubMed ID: 15944055
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug screening & the ADA.
    Watts C
    Occup Health Saf; 2001 Apr; 70(4):80-2. PubMed ID: 11326588
    [No Abstract]   [Full Text] [Related]  

  • 29. Case studies of drug testing in the workplace.
    Blume S; Cannella JM; Muir E; Stein P; Weihenmeyer E
    Bull N Y Acad Med; 1989 Feb; 65(2):215-42. PubMed ID: 2611457
    [No Abstract]   [Full Text] [Related]  

  • 30. Medicaid program; elimination of reimbursement under Medicaid for school administration expenditures and costs related to transportation of school-age children between home and school. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2007 Dec; 72(248):73635-51. PubMed ID: 18426056
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oral fluid testing: six considerations.
    Masterson LH
    Occup Health Saf; 2003 Aug; 72(8):78-80, 89. PubMed ID: 12945510
    [No Abstract]   [Full Text] [Related]  

  • 32. Mandatory drug testing: boon for public safety or launch of a witch-hunt?
    Sutherland R
    CMAJ; 1992 Apr; 146(7):1215-20. PubMed ID: 1285735
    [No Abstract]   [Full Text] [Related]  

  • 33. Tobacco, alcohol, and other drugs: the role of the pediatrician in prevention, identification, and management of substance abuse.
    Kulig JW;
    Pediatrics; 2005 Mar; 115(3):816-21. PubMed ID: 15741395
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The business case for workplace alcohol prevention.
    Knott B
    Occup Health Saf; 2012 Oct; 81(10):107-8, 110. PubMed ID: 23094492
    [No Abstract]   [Full Text] [Related]  

  • 35. Drug testing in the workplace: integrating medical review officer duties into occupational medicine.
    Smith DE; Glatt W; Tucker DE; Deutsch R; Seymour RB
    Occup Med; 2002; 17(1):79-90, v. PubMed ID: 11726338
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Public policy statement on drug testing as a component of addiction treatment and monitoring programs and in other clinical settings.
    J Addict Dis; 2003; 22(3):114-9. PubMed ID: 14621351
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug and alcohol testing. DOT's, Part 40: Implications for employers.
    Eden T
    Occup Health Saf; 2000 Jul; 69(7):84-6, 88. PubMed ID: 10902123
    [No Abstract]   [Full Text] [Related]  

  • 38. The effects of a drug testing program in the Navy.
    Cangianelli LA
    NIDA Res Monogr; 1989; 95():211-7. PubMed ID: 2640966
    [No Abstract]   [Full Text] [Related]  

  • 39. Drug testing in the private and public sectors.
    Walsh JM
    Bull N Y Acad Med; 1989 Feb; 65(2):166-72. PubMed ID: 2611451
    [No Abstract]   [Full Text] [Related]  

  • 40. Drug-testing service agencies.
    Smith RB
    Occup Health Saf; 1990 Apr; 59(4):33. PubMed ID: 2336235
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.